Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine vs Mexiletine for Non-Dystrophic Myotonia
NCT05017155Phase 3Unknown
- Sponsor
- University College London
- Start
- Aug 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lamotrigine in non-dystrophic myotonia (NDM), sponsored by University College London. Status: unknown.
02
Drugs
lamotrigine
03
Conditions
non-dystrophic myotonia (NDM)
Beyond the preview
Go deeper on NCT05017155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05017155.